UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 232

Sortiert nach

Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2

Molecules (Basel, Switzerland), 2020-09, Vol.25 (19), p.4459

2020

Volltextzugriff (PDF)

The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

Inflammopharmacology, 2013-06, Vol.21 (3), p.201-232

2013

Volltextzugriff (PDF)

Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome

PloS one, 2021-06, Vol.16 (6), p.e0252614-e0252614

2021

Volltextzugriff (PDF)

Potent Chlorambucil-Platinum(IV) Prodrugs

International journal of molecular sciences, 2022-09, Vol.23 (18), p.10471

2022

Volltextzugriff (PDF)

Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2181

2024

Volltextzugriff (PDF)

Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates

Molecules (Basel, Switzerland), 2022-10, Vol.27 (20), p.7120

2022

Volltextzugriff (PDF)

Prognostic and Predictive Value of Liquid Biopsy-Derived Androgen Receptor Variant 7 (AR-V7) in Prostate Cancer: A Systematic Review and Meta-Analysis

Frontiers in oncology, 2022-03, Vol.12, p.868031-868031

2022

Volltextzugriff (PDF)

Chemotherapeutic Potential of Chlorambucil-Platinum(IV) Prodrugs against Cisplatin-Resistant Colorectal Cancer Cells

International journal of molecular sciences, 2024-08, Vol.25 (15), p.8252

2024

Volltextzugriff (PDF)

Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells

Scientific reports, 2022-09, Vol.12 (1), p.16159-16159, Article 16159

2022

Volltextzugriff (PDF)

Human Group IIA Phospholipase A2—Three Decades on from Its Discovery

Molecules (Basel, Switzerland), 2021-11, Vol.26 (23), p.7267

2021

Volltextzugriff (PDF)

Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer

Cancers, 2024-07, Vol.16 (14), p.2544

2024

Volltextzugriff (PDF)

Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity

Pharmaceutics, 2022-04, Vol.14 (4), p.787

2022

Volltextzugriff (PDF)

Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents

Cancers, 2023-04, Vol.15 (9), p.2460

2023

Volltextzugriff (PDF)

Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy

Cancers, 2022-03, Vol.14 (7), p.1669

2022

Volltextzugriff (PDF)

New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use

International journal of cancer, 2014-06, Vol.134 (11), p.2523-2533

2014

Volltextzugriff (PDF)

The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

Prostate cancer, 2020, Vol.2020, p.7938280-16

2020

Volltextzugriff (PDF)

Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer

Clinical cancer research, 2008-12, Vol.14 (24), p.8070-8079

2008

Volltextzugriff (PDF)

Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell lines

Frontiers in nutrition (Lausanne), 2023-03, Vol.10, p.1119274-1119274

2023

Volltextzugriff (PDF)

Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations

Biochemical pharmacology, 2010-04, Vol.79 (8), p.1156-1164

2010

Volltextzugriff (PDF)

Oncogenic action of phospholipase A2 in prostate cancer

Cancer letters, 2006-08, Vol.240 (1), p.9-16

2006

Volltextzugriff (PDF)

A Bifunctional Role for Group IIA Secreted Phospholipase A2 in Human Rheumatoid Fibroblast-like Synoviocyte Arachidonic Acid Metabolism

The Journal of biological chemistry, 2011-01, Vol.286 (4), p.2492-2503

2011

Volltextzugriff (PDF)

Limitations of drug concentrations used in cell culture studies for understanding clinical responses of NSAIDs

Inflammopharmacology, 2021-10, Vol.29 (5), p.1261-1278

2021

Volltextzugriff (PDF)

Human TERT promoter mutations as a prognostic biomarker in glioma

Journal of cancer research and clinical oncology, 2021-04, Vol.147 (4), p.1007-1017

2021

Volltextzugriff (PDF)

Biomarkers in immune checkpoint inhibition therapy for cancer patients: what is the role of lymphocyte subsets and PD1/PD-L1?

Translational medicine communications, 2019-02, Vol.4 (1), p.1-13, Article 2

2019

Volltextzugriff (PDF)

Antibacterial actions of secreted phospholipases A2. Review

Biochimica et biophysica acta, 2008-01, Vol.1781 (1-2), p.1-9

2008

Volltextzugriff (PDF)

1 – 25 von 232

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(211)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(133)
Life Sciences & Biomedicine
(123)
Humans
(105)
Cardiovascular System & Cardiology
(59)
Cardiac & Cardiovascular Systems
(58)
Heart Failure
(56)
Male
(40)
Stroke Volume
(33)
Heart Failure - Drug Therapy
(30)
Female
(28)
Aged
(25)
Animals
(18)
Dapagliflozin
(17)
Cancer
(16)
Cosmic Microwave Background
(16)
Middle Aged
(16)
Benzhydryl Compounds - Therapeutic Use
(15)
Glucosides - Therapeutic Use
(15)
Biochemistry & Molecular Biology
(14)
Biological And Medical Sciences
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2

The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome

Potent Chlorambucil-Platinum(IV) Prodrugs

Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity

Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates

Prognostic and Predictive Value of Liquid Biopsy-Derived Androgen Receptor Variant 7 (AR-V7) in Prostate Cancer: A Systematic Review and Meta-Analysis

Chemotherapeutic Potential of Chlorambucil-Platinum(IV) Prodrugs against Cisplatin-Resistant Colorectal Cancer Cells

Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells

Human Group IIA Phospholipase A2—Three Decades on from Its Discovery

Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer

Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity

Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents

Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy

New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use

The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer

Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell lines

Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations

Oncogenic action of phospholipase A2 in prostate cancer

A Bifunctional Role for Group IIA Secreted Phospholipase A2 in Human Rheumatoid Fibroblast-like Synoviocyte Arachidonic Acid Metabolism

Limitations of drug concentrations used in cell culture studies for understanding clinical responses of NSAIDs

Human TERT promoter mutations as a prognostic biomarker in glioma

Biomarkers in immune checkpoint inhibition therapy for cancer patients: what is the role of lymphocyte subsets and PD1/PD-L1?

Antibacterial actions of secreted phospholipases A2. Review

Suchergebnisse filtern